HQY is a Zacks Rank #2 (Buy) stock, with a Growth Style Score of A and VGM Score of B. Earnings are expected to grow 37.3% ...

HealthEquity (HQY) shares soared 3.5% in the last trading session to close at $102.40. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares ...

Atria Investments Inc cut its stake in shares of HealthEquity, Inc. (NASDAQ:HQY – Free Report) by 19.5% in the 3rd quarter, ...

Fintel reports that on November 15, 2024, Goldman Sachs initiated coverage of HealthEquity (NasdaqGS:HQY) with a Neutral ...

This award recognizes Padia’s creative vision to develop the HealthEquity Immersion Experience — a project that showcases HealthEquity’s deep understanding of the client and member benefits journey ...

David Roman, an analyst from Goldman Sachs, has initiated a new Hold rating on Healthequity (HQY). David Roman has given his Hold rating due to ...

HealthEquity HQY shares ended the last trading session 9.8% higher at $97.95. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session.

BTIG raised the firm’s price target on HealthEquity (HQY) to $130 from $110 and keeps a Buy rating on the shares. The firm is citing improving policy fundamentals, better visibility into demand ...

The firm decreased its portfolio allocation in HQY by 7.21% over the last quarter. VTSMX - Vanguard Total Stock Market Index Fund Investor Shares holds 2,760K shares representing 3.16% ownership ...